Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin<i> in vitro</i>
Andra Tilgase, Pēteris Alberts(Maxygen (United States)), Liene Patetko(University of Latvia), Anna Ramata‐Stunda(University of Latvia), Ilze Blāķe(University of Latvia), Mārtiņs Borodušķis(University of Latvia)
Cited by 19
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179